SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-21-145367
Filing Date
2021-04-30
Accepted
2021-04-30 16:50:58
Documents
16
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d180817d10ka.htm   iXBRL 10-K/A 673012
2 EX-31.1 d180817dex311.htm EX-31.1 3634
3 EX-31.2 d180817dex312.htm EX-31.2 3665
  Complete submission text file 0001193125-21-145367.txt   939083

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA wve-20201231.xsd EX-101.SCH 4945
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE wve-20201231_cal.xml EX-101.CAL 656
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE wve-20201231_def.xml EX-101.DEF 1661
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE wve-20201231_lab.xml EX-101.LAB 21069
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wve-20201231_pre.xml EX-101.PRE 16652
9 EXTRACTED XBRL INSTANCE DOCUMENT d180817d10ka_htm.xml XML 8798
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-37627 | Film No.: 21879104
SIC: 2834 Pharmaceutical Preparations